Effective treatment of opioid use disorder (OUD) must target both the medical and psychosocial aspects of a patient's condition. This, in turn, requires a collaboration between medical providers and social supports. We would like to illustrate a key difficulty in this collaboration for some patients in our country: many post-discharge recovery houses continue to refuse to allow patients to remain on medication treatment for OUD (M-OUD). This barrier to M-OUD access in recovery houses is a significant obstacle to effective OUD treatment.
SAMHSA.2018 National Survey on Drug Use and Health (NSDUH):Methodological Summary and Definitions. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019.
2.
SchollL, SethP, KariisaM, WilsonN, BaldwinG. Drug and opioid-involved overdose deaths—United States, 2013–2017. Morbidity and Mortality Weekly Report. 2019;67(5152):1419.
3.
PolcinDL, KorchaR, BondJ, GallowayG. What did we learn from our study on sober living houses and where do we go from here?J Psychoactive Drugs.2010;42(4):425–433.
4.
CSAT. SAMHSA/CSAT Treatment Improvement Protocols. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Vol Report No.: (SMA) 12-4214. Rockville, MD: Substance Abuse and Mental Health Services Administration (US), Center for Substance Abuse Treatment; 2005.
5.
MaJ, BaoYP, WangRJ, . Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry.2019;24:1868–1883.
6.
FischerPJ, BreakeyWR. The epidemiology of alcohol, drug, and mental disorders among homeless persons. Am Psychol.1991;46(11):1115–1128.
7.
SealKH, KralAH, GeeL, . Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health.2001;91(11):1842–1846.
8.
HwangSW, LebowJM, BiererMF, O'ConnellJJ, OravE, BrennanTA. Risk factors for death in homeless adults in boston. Arch Intern Med.1998;158(13):1454–1460.
9.
O'BrienJ, SadwithT, CrozeC, ParkerS. Review of State Strategies to Expand Medication-Assisted Treatment: A Report to the Laura and John Arnold Foundation. Boston, MA: Technical Assistance Collaborative; 2019.
10.
KnudsenHK, AbrahamAJ, RomanPM. Adoption and implementation of medications in addiction treatment programs. J Addict Med.2011;5(1):21–27.
11.
SAMHSA. Recovery Housing: Best Practices and Suggested Guidelines. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019.
12.
NARR. MAT-Capable Recovery Residences: How State Policymakers Can Enhance and Expand Capacity to Adequately Support Medication Assisted Recovery. St Paul, MN: National Alliance for Recovery Residences; 2018:1–17.
13.
RomanPM, AbrahamAJ, KnudsenHK. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict Behav.2011;36(6):584–589.
14.
MajerJM, BeasleyC, SteckerE, . Oxford house residents’ attitudes toward medication assisted treatment use in fellow residents. Commun Ment Health J.2018;54(5):571–577.
15.
DailardC, NashE. State responses to substance abuse among pregnant women. Guttmacher Rep Publ Pol.2000;3(6):3–6.
16.
ASAM.Medicaid Coverage of Medications for the Treatment of Opioid Use Disorder in Tennessee. Rockville, MD: American Society of Addiction Medicine; 2014.
17.
EyreE. Trump officials seek opioid solutions in WV. Charleston Gazette-Mail. May 9, 2017.
18.
JackHE, OllerD, KellyJ, MagidsonJF, WakemanSE. Addressing substance use disorder in primary care: the role, integration, and impact of recovery coaches. Subst Abuse.2018;39(3):307–314.
